Free Trial
OTCMKTS:ENZC

Enzolytics (ENZC) Stock Price, News & Analysis

Enzolytics logo
$0.0006 0.00 (-14.29%)
As of 04/17/2025 03:59 PM Eastern

About Enzolytics Stock (OTCMKTS:ENZC)

Key Stats

Today's Range
$0.0006
$0.0007
50-Day Range
N/A
52-Week Range
$0.0006
$0.0055
Volume
10.34 million shs
Average Volume
4.99 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.

Receive ENZC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzolytics and its competitors with MarketBeat's FREE daily newsletter.

ENZC Stock News Headlines

Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update
Enzolytics, Inc. (ENZC)
Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
Enzolytics Stock (OTC:ENZC) Insider Trades
See More Headlines

ENZC Stock Analysis - Frequently Asked Questions

Enzolytics' stock was trading at $0.0010 at the beginning of 2025. Since then, ENZC shares have decreased by 40.0% and is now trading at $0.0006.
View the best growth stocks for 2025 here
.

Shares of ENZC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzolytics investors own include HUMBL (HMBL), Bionano Genomics (BNGO), Artificial Intelligence Technology Solutions (AITX), Meta Platforms (META), SNDL (SNDL), Tesla (TSLA).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Entertainment
Current Symbol
OTCMKTS:ENZC
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:ENZC) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners